Vopratelimab

• CAT Number: I042215
• CAS Number: 2039148-04-2
• Purity: ≥95%

Vopratelimab（Cat No.:I042215）is an investigational monoclonal antibody designed to target and activate the immune checkpoint receptor PD-1 (programmed cell death protein 1) on T cells. It works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, which are often exploited by tumors to suppress immune responses. By inhibiting this pathway, vopratelimab aims to enhance the body’s immune system in fighting cancer. It is being explored in clinical trials for various solid tumors and hematological cancers, with a focus on improving immune responses and patient outcomes.